Peta Sally Helena Braddock

Title: Peta Sally Helena Braddock: Innovator in Antibody Technology

Introduction

Peta Sally Helena Braddock is a notable inventor based in Huntingdon, GB. She has made significant contributions to the field of antibody technology, particularly in the development of specific binding members that target TGF-beta. With a total of two patents to her name, her work has implications for treating various medical conditions.

Latest Patents

Braddock's latest patents include inventions that provide specific binding members in the form of antibody variable domains. These are based on the CDR3 sequences of the antibody VH regions of SL15 and JT182. The antibodies developed have shown strong neutralizing activity for TGF-beta and are useful in treating conditions associated with excess TGF-beta activity, such as fibrosis, immune responses, and tumor progression.

Career Highlights

Peta Braddock is associated with Cambridge Antibody Technology Limited, where she has been instrumental in advancing research in antibody therapies. Her innovative approaches have positioned her as a key figure in the biotechnology sector.

Collaborations

Braddock has collaborated with notable colleagues, including Julia Elizabeth Thompson and Simon Nicholas Lennard. These partnerships have further enhanced her research and development efforts in the field.

Conclusion

Peta Sally Helena Braddock is a pioneering inventor whose work in antibody technology is making a significant impact in medical research and treatment. Her contributions continue to advance the understanding and application of specific binding members in therapeutic contexts.